Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about gene editing Recent news which mentions gene editing Biotech ETF SBIO Sees Buy Signal Amid Hot Returns December 14, 2023 Tickers ACAD ALPS SBIO ZLAB Tags patents gene editing ZLAB From ETF Trends Play US Gene Treatment Approval in SBIO December 07, 2023 Tickers ALPS SBIO Tags CRISPR gene treatment SBIO From ETF Trends Bill Gates Gets Excited About Future Of Tech That Has 'Revolutionized Health' Over Past Decade February 06, 2023 Tickers TECH Tags Biotech Bill Gates Benzinga From Benzinga Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection September 19, 2022 Tickers BEAM Tags Preclinical Phase Market News BEAM From Benzinga FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials March 15, 2022 Tickers BLUE NTLA Tags Small Cap General FDA From Benzinga Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents March 01, 2022 Tickers EDIT Tags Legal General Small Cap From Benzinga Intellia Shares Updated Data On Gene Editing Durability In Rare Disease March 01, 2022 Tickers NTLA REGN Tags REGN Briefs Biotech From Benzinga Sarepta Bets On GenEdit's Nanoparticles' In $57M Gene Editing Partnership February 01, 2022 Tickers SRPT Tags Market News General SRPT From Benzinga Pfizer, Beam Ink Multi-Target Research Collaboration For In Vivo Base Editing Programs January 10, 2022 Tickers BEAM PFE Tags General Benzinga Biotech From Benzinga Jennifer Doudna Spinout Mammoth Inks $700M CRISPR Deal With Vertex October 26, 2021 Tickers VRTX Tags News Gene Editing Health Care From Benzinga Sana Obtains License To Beam Therapeutics' CRISPR Cas12b Gene Editing Technology October 19, 2021 Tickers BEAM SANA Tags Gene Editing News Trading Ideas From Benzinga Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients October 06, 2021 Tickers NTLA Tags Market News Gene Editing News From Benzinga Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate September 29, 2021 Tickers EDIT Tags Market News why it's moving Phase 1 Trial From Benzinga Wave Life Sciences Shows Durable ADAR-Editing In Multiple Tissues In Animal Studies September 29, 2021 Tickers WVE Tags Preclinical Phase Market News General From Benzinga Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection September 27, 2021 Tickers BEAM Tags Gene Editing News Biotech From Benzinga Beam Therapeutics' Formulated LNP Show Tolerance, Early Storage Stability In Animal Studies September 23, 2021 Tickers BEAM Tags General BEAM Preclinical Phase From Benzinga How Colossal sold investors on a quest to resurrect a woolly mammoth September 13, 2021 Tickers TC Tags mammoth Science CRISPR From TechCrunch Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn September 09, 2021 Tickers TC Tags jennifer doudna therapeutics CRISPR From TechCrunch Shape Therapeutics, Roche Form $3B RNA Editing Collaboration August 24, 2021 Tickers RHHBF RHHBY RHHVF Tags Health Care Gene Editing News From Benzinga Vertex Inks Potential $1.2B Gene-Editing Pact With Arbor Biotechnologies August 24, 2021 Tickers VRTX Tags beta/thalassemia General Benzinga From Benzinga Editas Medicine Unveils Preclinical Data From New Gene Editing Technology August 23, 2021 Tickers EDIT Tags Health Care Trading Ideas EDIT From Benzinga New Technologies Driving the Future of Plant Breeding August 10, 2021 Tags Innovation & Technology Bayer Plant Breeding From 3BL Media: Corporate Social Responsibility, Energy and Health News Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish July 20, 2021 Tickers GENE GRPH Tags Analyst Color Market News Geoff Meacham From Benzinga Heart Disease Company Tenaya Therapeutics Files For $100M US IPO July 12, 2021 Tickers FPX IPO IPOS Tags IPOs General Biotech From Benzinga WHO Issues Framework For Governance For Gene Editing Technologies July 12, 2021 Tickers BEAM CRSP EDIT NTLA Tags General Biotech CRSP From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.